Mutations in the HFE gene and their interaction with exogenous risk factors in hepatocellular carcinoma

被引:30
|
作者
Fargion, S
Stazi, MA
Fracanzani, AL
Mattioli, M
Sampietro, M
Tavazzi, D
Bertelli, C
Patriarca, V
Mariani, C
Fiorelli, G
机构
[1] Univ Milan, IRCCS, Osped Maggiore, Dipartimento Med Interna, I-20133 Milan, Italy
[2] Ist Super Sanita, I-00161 Rome, Italy
关键词
HBV; HCV infection; alcohol abuse; C282YH63D mutations;
D O I
10.1006/bcmd.2001.0411
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The possible role of iron in facilitating the development of liver cancer is still debated, The aims of this study were to define the prevalence of the mutations 845G -->A, and 187C -->G (C282Y and H63D) in the HFE gene associated with hereditary hemochromatosis in Italian patients with hepatocellular carcinoma occurring in cirrhosis and to analyze the interaction between these mutations and other established risk factors for hepatocellular carcinoma. The HFE gene mutations, performed by polymerase chain reaction, were analyzed in 81 patients (63 males, 18 females) with hepatocellular carcinoma. None of the patients had a phenotype compatible with homozygous hereditary hemochromatosis. Interaction between I HFE mutations and exogenous risk factors was analyzed by collecting information on alcohol consumption, hepatitis B and C virus infections, and iron status at the time of diagnosis of chronic liver disease. This analysis was performed only in males to rule out gender influence on patients' iron status by using the case-only approach specifically designed to estimate departure from multiplicative risk ratios under the assumption of independence between genotype and environmental exposure. The prevalence of the C282Y mutation was significantly higher in patients with hepatocellular carcinoma than in normal controls (8.6% vs 1.6%, P <0.03). At univariate analysis, iron overload was significantly associated with both HFE mutations (P <0.0001), whereas ongoing hepatitis B virus infection was associated with the C282Y mutation (P <0.05). By multivariate analysis, a trend for an increased risk of being positive for hepatitis virus markers (OR2.9, CI 95%0.9-9.5) and of having been alcohol abusers (OR3, CI 95%0.7-14) was observed in patients heterozygous for the HFE mutations, These data indicate that the prevalence of the main mutation associated with hereditary hemochromatosis is significantly higher in cirrhotic Italian patients with hepatocellular carcinoma compared to a normal population and suggest that heterozygotes for HFE mutations exposed to hepatitis virus infections or who had been alcohol abusers could have an increased risk of developing cirrhosis and later liver cancer than people without the mutations exposed to the same risk factors, (C) 2001 Academic Press.
引用
收藏
页码:505 / 511
页数:7
相关论文
共 50 条
  • [21] Risk of Hepatocellular Carcinoma in Patients with Various HFE Genotypes
    Yamini Natarajan
    Parth Patel
    Jinna Chu
    Xian Yu
    Ruben Hernaez
    Hashem El-Serag
    Fasiha Kanwal
    Digestive Diseases and Sciences, 2023, 68 : 312 - 322
  • [22] Prospective influence of hfe gene mutations and liver iron overload on the risk of hepatocellular carcinoma occurrence in patients with alcoholic or HCV-related cirrhosis
    Nahon, P.
    Sutton, A.
    Rufat, P.
    Thabut, G.
    Ziol, M.
    Fagard, R.
    Schischmanoff, P. O.
    Vidaud, D.
    Charnaux, N.
    Ganne-Carrie, N.
    Trinchet, J. C.
    Gattegno, L.
    Beaugrand, M.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S108 - S108
  • [23] Effect of PTPRD rs2279776 gene and interaction with hepatitis B virus mutations on the risk of hepatocellular carcinoma
    邓阳
    ChinaMedicalAbstracts(InternalMedicine), 2014, 31 (01) : 45 - 45
  • [24] Heterozygosity for HFE gene mutations and alcohol abuse are additive risk factors for biochemical iron overload
    Moodie, S
    Ang, L
    Stenner, J
    Levin, GE
    Maxwell, JD
    JOURNAL OF HEPATOLOGY, 2000, 32 : 224 - 224
  • [25] Carriage of HFE mutations and outcome of surgical resection for hepatocellular carcinoma in cirrhotic patients
    Pirisi, M
    Toniutto, P
    Uzzau, A
    Fabris, C
    Avellini, C
    Scott, C
    Apollonio, L
    Beltrami, CA
    Bresadola, F
    CANCER, 2000, 89 (02) : 297 - 302
  • [26] Are hemochromatosis gene (HFE) mutations a risk factor for colon cancer?
    Shaheen, NJ
    Sandler, RS
    Silverman, LM
    Keku, TO
    Lawrence, LB
    Martin, CF
    Maynard, R
    Rohlfs, EM
    GASTROENTEROLOGY, 2000, 118 (04) : A703 - A703
  • [27] HFE gene mutations in Chile
    Wohllk, N
    Zapata, R
    Acuña, M
    Reyes, H
    Navarro, A
    Roa, I
    Roa, JC
    ANNALS OF INTERNAL MEDICINE, 2003, 139 (08) : 708 - 709
  • [28] Risk factors for hepatocellular carcinoma
    Nalmpantidis, G.
    Taloumtzis, H.
    Ilias, A.
    ARCHIVES OF HELLENIC MEDICINE, 2011, 28 (03): : 336 - 344
  • [29] Risk factors for hepatocellular carcinoma
    Lai, Shih-Wei
    CANCER, 2019, 125 (03) : 482 - 482
  • [30] Risk factors of hepatocellular carcinoma
    Covini, G
    Colombo, M
    EUROCANCER 96 - PROCEEDINGS OF THE NINTH CONGRESS, 1996, : 139 - 140